Found: 22
Select item for more details and to access through your institution.
Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1282754
- By:
- Publication type:
- Article
Neuroimmunology of rabies: New insights into an ancient disease.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 10, p. 1, doi. 10.1002/jmv.29042
- By:
- Publication type:
- Article
Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1243516
- By:
- Publication type:
- Article
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach.
- Published in:
- NPJ Aging, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41514-023-00118-0
- By:
- Publication type:
- Article
Rabies virus variants from bats closely related to variants found in marmosets (Callithrix jacchus), a neglected source of human rabies infection in Brazil.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 8, p. 1, doi. 10.1002/jmv.29046
- By:
- Publication type:
- Article
Reducing the Immunogenicity of Pulchellin A-Chain, Ribosome-Inactivating Protein Type 2, by Computational Protein Engineering for Potential New Immunotoxins.
- Published in:
- J: Multidisciplinary Scientific Journal, 2023, v. 6, n. 1, p. 85, doi. 10.3390/j6010006
- By:
- Publication type:
- Article
Vaccines against Emerging and Neglected Infectious Diseases: An Overview.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1385, doi. 10.3390/vaccines10091385
- By:
- Publication type:
- Article
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 5, p. 847, doi. 10.3390/cells11050847
- By:
- Publication type:
- Article
Study of Viral Photoinactivation by UV-C Light and Photosensitizer Using a Pseudotyped Model.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 3, p. 683, doi. 10.3390/pharmaceutics14030683
- By:
- Publication type:
- Article
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1409, doi. 10.3390/vaccines9121409
- By:
- Publication type:
- Article
The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations.
- Published in:
- PLoS Neglected Tropical Diseases, 2021, v. 15, n. 8, p. 1, doi. 10.1371/journal.pntd.0009575
- By:
- Publication type:
- Article
Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00242-y
- By:
- Publication type:
- Article
A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut Allergy.
- Published in:
- International Archives of Allergy & Immunology, 2020, v. 181, n. 5, p. 334, doi. 10.1159/000505917
- By:
- Publication type:
- Article
Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 116, doi. 10.3390/vaccines8010116
- By:
- Publication type:
- Article
Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 72, doi. 10.3390/vaccines7030072
- By:
- Publication type:
- Article
Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands—A Role for CCL2.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01679
- By:
- Publication type:
- Article
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01015
- By:
- Publication type:
- Article
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines.
- Published in:
- Diseases, 2018, v. 6, n. 4, p. 107, doi. 10.3390/diseases6040107
- By:
- Publication type:
- Article
Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.
- Published in:
- Vaccines, 2017, v. 5, n. 4, p. 32, doi. 10.3390/vaccines5040032
- By:
- Publication type:
- Article
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 10, doi. 10.3390/vaccines5020010
- By:
- Publication type:
- Article
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines.
- Published in:
- Frontiers in Immunology, 2017, v. 8, p. 1, doi. 10.3389/fimmu.2017.00226
- By:
- Publication type:
- Article